Erin M. Bange

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Erin M. Bange, Nicholas Han, Paul Wileyto et al. · Nature Medicine · 2021 · 503 citations · Full text

Impact of <i>KRAS</i> and <i>TP53</i> Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With <i>STK11</i>-Mutated Advanced Non–Small-Cell Lung Cancer

Erin M. Bange, Melina E. Marmarelis, Wei‐Ting Hwang et al. · JCO Precision Oncology · 2019 · 70 citations

Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

Erin M. Bange, Abigail Doucette, Peter Gabriel et al. · JCO Oncology Practice · 2020 · 59 citations · Full text

Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients

Lova Sun, Sanjna Surya, Anh N. Le et al. · JNCI Cancer Spectrum · 2020 · 43 citations · Full text

Cancer Management, Epidemiology Of Cancer, Health Care Exposure +19

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer

Erin M. Bange, Nicholas Han, E. Paul Wileyto et al. · 2021 · 43 citations · Full text